Further evidence of dose-dependent APP pathology is provided by rare individuals with partial trisomy 21 (i.e., with partial triplication of chromosome 21 but without APP gene triplication), having normal AD biomarkers in later years [22,23]. Here, APP is linked to Alzheimer disease.